PrEP rollout has cut new HIV diagnoses, finds Australian study
Study results support the population-level effectiveness of pre-exposure prophylaxis for HIV in reducing new diagnoses and suggest that further rollout should be prioritised
Rollout of pre-exposure prophylaxis (PrEP) for HIV has resulted in a rapid decrease of new infections among men who have sex with men, according to data collected in New South Wales, Australia.
The study, which was published in The Lancet HIV (17 October 2018), involved 3,069 sexually active men at high risk of contracting HIV who received daily tenofovir disoproxil fumarate/emtricitabine and attended a follow-up visit at 12 months or later at which their HIV status was tested.
Overall, two men were infected with HIV during 4,100 person-years of follow-up and both had been non-adherent to PrEP. This equated to an incidence of 0.048 per 100 person-years.
Additionally, the researchers looked at population-level data and found 221 new HIV diagnoses in the year after PrEP rollout, compared with 295 new diagnoses in the year before. The team noted that this was the lowest number of HIV diagnoses in New South Wales since surveillance began in 1985.
“Our results support the population-level effectiveness of PrEP one year after rapid PrEP implementation at scale,” said lead author Andrew Grulich from the Kirby Institute, University of New South Wales.
“Rollout should be prioritised as a crucial component of HIV prevention in epidemics predominantly affecting men who have sex with men.”
Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20205626
Recommended from Pharmaceutical Press
This new edition of Dale and Appelbe's Pharmacy and Medicines Law is the definitive guide to law and ethics for pharmacy practice in the UK. It covers law and professional regulation and is firmly established as the definitive student textbook and reference work on this subject in the UK. Fully updated to include changes to pharmacy laws and regulation.£57.00
Pharmacy Registration Assessment Questions 2 features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own. All questions are in line with current GPhC guidance, enabling you to prepare for the pharmaceutical pre-registration exam with confidence.£35.00
An introduction to economic evaluation specific to healthcare, for those with little or no knowledge of economics. Covers cost effectiveness, cost utility and cost benefit analysis.£33.00
Pharmacy Registration Assessment Questions 3 is the third volume in a series that follows on from the previous, highly popular Pharmacy Registration Assessment Questions 2. It features more than 400 entirely new, closed book and calculation questions. It can be used in conjunction with the previous volume or on its own.£35.00
Pharmacy Registration Assessment Questions features over 400 closed book and calculation questions. With the registration exam having gone through a complete transformation in 2016, this volume has been developed around the new General Pharmaceutical Council (GPhC) guidelines.£33.00